抗万科胺素耐药性肠球菌利用抗生素诱导的先天性免疫缺陷.
Katharina Brandl1, George Plitas, Coralia N Mihu
1Infectious Diseases Service, Department of Medicine, Immunology Program, Sloan-Kettering Institute, New York, New York, USA.
Nature
|August 30, 2008
概括
广谱抗生素降低RegIIIgamma,一个关键的免疫蛋白,允许危险的VRE感染. 通过托尔类受体刺激恢复RegIIIgamma提供了一种对抗抗生素耐药细菌的方法.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 抗生素耐药的细菌感染,如抗万科胺素耐药性肠球菌 (VRE),是医疗保健面临的重大挑战.
- 使用抗生素促进这些感染的机制尚未完全理解.
研究的目的:
- 研究抗生素治疗对肠道免疫防御对抗生素耐药细菌的影响.
- 确定分子机制,将抗生素治疗与增加对VRE的敏感性联系起来.
主要方法:
- 用抗生素治疗小鼠,以评估肠道基因表达的变化.
- 在肠道中对抗万科胺素抗性肠球菌 (VRE) 殖民的量化.
- 用脂聚糖 (LPS) 刺激托尔类受体4 (TLR4),以评估免疫反应.
主要成果:
- 抗生素治疗显著降低了小鼠的肠道RegIIIgamma (Reg3g) 表达.
- 降低RegIIIgamma水平与增加的VRE殖民化相关.
- 口服的脂聚糖 (LPS) 恢复了RegIIIgamma表达,并增强了对VRE的抵抗力.
结论:
- 抗生素诱导的RegIIIgamma抑制会损害与生俱来的粘膜免疫力,对抗像VRE这样的格兰阳性病原体.
- 准托尔类受体是恢复粘膜防御和对抗抗生素耐药性感染的潜在策略.
相关概念视频
Defense Against Bacterial Pathogens
3.0K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.0K
Transduction
3.0K
Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome...
3.0K
Development of Antibiotic Resistance
2.0K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Colonisation of Pathogens
77
Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
77
Mechanism of Antibiotic Resistance in MRSA
219
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
Clinical Significance of Antibiotic Resistance
90
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90


